FDAFDA · Food and drugs·Recall number D-0083-2022
Dr. Reddy's Ezetimibe and Simvastatin Tablets, 10 mg/80 mg, a) 30 count (NDC 43598-745-30), b) 90 count (NDC 43598-745-90), and c) 500 count (NDC 43598-745-05) bottles, Rx Only, Manufactured by: Dr. Reddy's Laboratories LA LLC, Shreveport, LA 71106, USA, Distributed by: Dr. Reddy's Laboratories Inc., Princeton, NJ 08540 USA
Published November 10, 2021 · Recall initiated: October 5, 2021
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Excipient Specifications; product manufactured using an excipient found to be OOS for conductivity
What to do
Voluntary: Firm initiated · Letter
Recall details
- Brand
- EZETIMIBE AND SIMVASTATIN
- Manufacturer
- Dr. Reddy's Laboratories, Inc.
- Distributor
- Nationwide in the US
- UPC
- 0343598745909
- Lot
- a) L100160, exp 01/2023 b) L100249, exp 01/2023 c) L100250, exp 01/2023
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.